Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Inadomi

Showing results (21-30 of 166) with videos related to

Pageof 17
Sort By:
Journal of Gastroenterology and Hepatology|January 6, 2009
Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherenceJohn M Inadomi
Gastroenterology|March 30, 2022
Trying to Be American: A Personal Reflection of the Pervasiveness of Systemic Racism and Possible Steps to Mitigate Its ImpactJohn M Inadomi
Gastroenterology|August 25, 2012
Is 325 mg of prevention worth a pound of cure?John M Inadomi
Digestive Diseases and Sciences|June 28, 2018
Screening and Surveillance for Barrett's Esophagus: Is It Cost-Effective?John M Inadomi, Nina Saxena
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 2, 2006
Exploring utilities and outcomes with infliximab therapyJohn M Inadomi, Jonathan Terdiman
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2004
An evidence-based medicine approach to economic studies: assessing the cost-effectiveness of competing strategies for colorectal cancer screeningJohn M Inadomi, Amnon Sonnenberg
BMJ (Clinical Research Ed.)|September 16, 2021
Screening and prevention of colorectal cancerPriyanka Kanth, John M Inadomi
Translational Gastroenterology and Hepatology|February 1, 2019
Endoscopic surveillance or ablation for Barrett's esophagus?John M Inadomi, Nina Saxena
Gastrointestinal Endoscopy Clinics of North America|June 5, 2017
Effectiveness and Cost-Effectiveness of Endoscopic Screening and SurveillanceNina Saxena, John M Inadomi
Gastroenterology|December 7, 2021
How to Succeed in Digestive ResearchAmnon Sonnenberg, John M Inadomi
Pageof 17

Showing results (21-30 of 166) with videos related to

Sort By:
Pageof 17
Journal of Gastroenterology and Hepatology|January 6, 2009
Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherenceJohn M Inadomi
Gastroenterology|March 30, 2022
Trying to Be American: A Personal Reflection of the Pervasiveness of Systemic Racism and Possible Steps to Mitigate Its ImpactJohn M Inadomi
Gastroenterology|August 25, 2012
Is 325 mg of prevention worth a pound of cure?John M Inadomi
Digestive Diseases and Sciences|June 28, 2018
Screening and Surveillance for Barrett's Esophagus: Is It Cost-Effective?John M Inadomi, Nina Saxena
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 2, 2006
Exploring utilities and outcomes with infliximab therapyJohn M Inadomi, Jonathan Terdiman
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2004
An evidence-based medicine approach to economic studies: assessing the cost-effectiveness of competing strategies for colorectal cancer screeningJohn M Inadomi, Amnon Sonnenberg
BMJ (Clinical Research Ed.)|September 16, 2021
Screening and prevention of colorectal cancerPriyanka Kanth, John M Inadomi
Translational Gastroenterology and Hepatology|February 1, 2019
Endoscopic surveillance or ablation for Barrett's esophagus?John M Inadomi, Nina Saxena
Gastrointestinal Endoscopy Clinics of North America|June 5, 2017
Effectiveness and Cost-Effectiveness of Endoscopic Screening and SurveillanceNina Saxena, John M Inadomi
Gastroenterology|December 7, 2021
How to Succeed in Digestive ResearchAmnon Sonnenberg, John M Inadomi
Pageof 17